Crossover Trial of AD109 in Obstructive Sleep Apnea
Condition:   Obstructive Sleep Apnea Interventions:   Drug: AD109;   Drug: Atomoxetine;   Drug: R-oxybutynin;   Drug: Placebo Sponsor:   Apnimed Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials